Blastomycosis classification

Jump to navigation Jump to search

Blastomycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Blastomycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Blastomycosis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Blastomycosis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Blastomycosis classification

CDC on Blastomycosis classification

Blastomycosis classification in the news

Blogs on Blastomycosis classification

Directions to Hospitals Treating Blastomycosis

Risk calculators and risk factors for Blastomycosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Classification

Based on duration of symptoms

  • Acute: If the duration of symptoms is less than 4-6 weeks
  • Chronic: If the symptoms persist for more than 6 weeks.

Based on organ involved

  • Pulmonary Blastomycosis' :Lungs are the most common site of primary infection in blastomycosis.
  • Extra-pulmonary Blastomycosis: The most common extra pulmonary sites involved in blastomycosis are skin, bone, genitourinary and CNS.